ATE202100T1 - Triazolderivate - Google Patents

Triazolderivate

Info

Publication number
ATE202100T1
ATE202100T1 AT95906415T AT95906415T ATE202100T1 AT E202100 T1 ATE202100 T1 AT E202100T1 AT 95906415 T AT95906415 T AT 95906415T AT 95906415 T AT95906415 T AT 95906415T AT E202100 T1 ATE202100 T1 AT E202100T1
Authority
AT
Austria
Prior art keywords
alkyl
heteroaryl
aryl
pct
alkynyl
Prior art date
Application number
AT95906415T
Other languages
English (en)
Inventor
Victor Giulio Matassa
Francine Sternfeld
Leslie Joseph Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE202100T1 publication Critical patent/ATE202100T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT95906415T 1994-02-02 1995-01-24 Triazolderivate ATE202100T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9402016A GB9402016D0 (en) 1994-02-02 1994-02-02 Therapeutic agents
PCT/GB1995/000134 WO1995021166A1 (en) 1994-02-02 1995-01-24 Triazole derivatives

Publications (1)

Publication Number Publication Date
ATE202100T1 true ATE202100T1 (de) 2001-06-15

Family

ID=10749758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906415T ATE202100T1 (de) 1994-02-02 1995-01-24 Triazolderivate

Country Status (9)

Country Link
US (1) US5902819A (de)
EP (1) EP0741722B1 (de)
JP (1) JPH09508408A (de)
AT (1) ATE202100T1 (de)
AU (1) AU685219B2 (de)
CA (1) CA2182196A1 (de)
DE (1) DE69521295T2 (de)
GB (1) GB9402016D0 (de)
WO (1) WO1995021166A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523583D0 (en) * 1995-11-17 1996-01-17 Merck Sharp & Dohme Therapeutic agents
GB9610978D0 (en) * 1996-05-24 1996-07-31 Merck Sharp & Dohme Therapeutic agents
FR2767827A1 (fr) * 1997-09-03 1999-02-26 Adir Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
WO1993018029A1 (en) * 1992-03-13 1993-09-16 Merck Sharp & Dohme Limited Imidazole, triazole and tetrazole derivatives
KR0179074B1 (ko) * 1992-04-10 1999-03-20 알렌 제이. 스피겔 5-ht1 작용물질로서의 아실아미노인돌 유도체
CA2138649A1 (en) * 1992-07-24 1994-02-03 Raymond Baker Imidazole, triazole and tetrazole derivatives
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them

Also Published As

Publication number Publication date
CA2182196A1 (en) 1995-08-10
EP0741722B1 (de) 2001-06-13
DE69521295D1 (de) 2001-07-19
JPH09508408A (ja) 1997-08-26
GB9402016D0 (en) 1994-03-30
WO1995021166A1 (en) 1995-08-10
DE69521295T2 (de) 2001-11-08
US5902819A (en) 1999-05-11
AU1461395A (en) 1995-08-21
EP0741722A1 (de) 1996-11-13
AU685219B2 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
SE0104332D0 (sv) Therapeutic agents
NO20055714L (no) Inhibitorer av fosfatidylinositol 3-kinase
ATE427300T1 (de) Heterocyclisch substituierte amide als calpainhemmer
ATE383338T1 (de) N-(phenyl(piperidin-2-yl)methyl)benzamid-deriva e,verfahren zu deren herstellung und ihre therapeutische verwendung
IS4588A (is) Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra
ATE194340T1 (de) Aminomethylen substituierte heterocyclische verbindungen und ihre verwendung alssubstanz p antagonisten
PL338129A1 (en) Crystalline form of a derivative of n-phenyl-2-dipyrimidin amine, methods of obtaining same and apllication thereof
ATE522525T1 (de) Arylsubstituierte pyrazolamidverbindungen, die als kinase-inhibitoren von nutzen sind
ATE206122T1 (de) Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind
ATE484495T1 (de) Fungizide
IS2020B (is) Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra
ATE177096T1 (de) 4-substituierte 1,2,4-triazolderivate
DE69231445D1 (de) Triazole enthaltende antifungizide mittel
ATE72431T1 (de) 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren.
DE69317439D1 (de) Azoxycyanbenzol-Derivate
ATE185560T1 (de) Von pyridin und imidazol abgeleitete mittel für kardiovaskuläre krankheiten
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
ATE399755T1 (de) Aminoalkoholderivate, pharmazeutische zusammensetzungen, die diese enthalten, und verwendung davon
ATE202100T1 (de) Triazolderivate
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
HRP20030810B1 (en) Novel fungicide compositions based on pyridylmethylbenzamide and propamocarb derivative
NO971424L (no) Nye heterocyklisk substituerte imidazolo-kinoksalinoner, deres fremstilling og anvendelse
ES2195016T3 (es) Medicamento contra la trombocitopenia.
ATE338749T1 (de) Derivate von 3-phenyl-n-(2-(4-benzyl)piperidin-1- yl)ethyl) acrylamid mit ccr-3-rezeptor antagonistischer wirkung zur verwendung bei der behandlung von entzündungen und allergischen leiden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties